{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:3760"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:3760","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Mutation analysis of wolfram syndrome patients and functional study of the Wolframin protein","abstract":"Mutations of the WFS1 gene are responsible for most cases of Wolfram syndrome (WS), a rare, recessively inherited neurodegenerative disorder characterised by juvenile-onset nonautoimmune diabetes mellitus and optic atrophy. Variants of \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) are also associated with non-syndromic hearing loss and type-2 diabetes. Understanding the function of the \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) protein-product wolframin, would enable developments in targeted therapy for WS patients and important insights to its possible contribution to type-2 diabetes pathogenesis. This study was aimed at expanding the spectrum of WS-associated genetic mutations and clinical data, and investigating the molecular mechanisms responsible for phenotypic variation associated with \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\)- mutation. The mutational and phenotypic spectrum of WS is broadened by our report of novel \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) mutations and a case of \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x32}\\)-associated WS. New perspectives on the molecular mechanisms linking mutation to disease manifestation are also taken by characterisation of representative WFS1 mutations specific to phenotype, identification of potentially novel \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) interacting partners, and the first evidence linking WFS1 with the exocrine pancreas. Our data suggests that some \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\)-mutations may allow residual protein function and these findings lay the groundwork for future functional investigation of mutated wolframin to explore this hypothesis further.","abstract_html":"Mutations of the WFS1 gene are responsible for most cases of Wolfram syndrome (WS), a rare, recessively inherited neurodegenerative disorder characterised by juvenile-onset nonautoimmune diabetes mellitus and optic atrophy. Variants of \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) are also associated with non-syndromic hearing loss and type-2 diabetes. Understanding the function of the \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) protein-product wolframin, would enable developments in targeted therapy for WS patients and important insights to its possible contribution to type-2 diabetes pathogenesis. This study was aimed at expanding the spectrum of WS-associated genetic mutations and clinical data, and investigating the molecular mechanisms responsible for phenotypic variation associated with \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\)- mutation. The mutational and phenotypic spectrum of WS is broadened by our report of novel \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) mutations and a case of \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x32}\\)-associated WS. New perspectives on the molecular mechanisms linking mutation to disease manifestation are also taken by characterisation of representative WFS1 mutations specific to phenotype, identification of potentially novel \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) interacting partners, and the first evidence linking WFS1 with the exocrine pancreas. Our data suggests that some \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\)-mutations may allow residual protein function and these findings lay the groundwork for future functional investigation of mutated wolframin to explore this hypothesis further.","abstract_has_math":true,"creators":["Prince, Samantha"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013-07","date_published":"2013-07","updated_at":"2026-11-19T09:27:23Z","subjects":["QH301 Biology","QH426 Genetics","RC Internal medicine"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/3760/1/Prince12PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A3760","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["mrc"]},{"key":"dc:creator","label":"Author","values":["Prince, Samantha"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2013-07"]},{"key":"dc:date.issued","label":"Date","values":["2013-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Department of Medical and Molecular Genetics, School of Clinical and Experimental Medicine"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/3760/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QH301 Biology","QH426 Genetics","RC Internal medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/3760/1/Prince12PhD.pdf","http://etheses.bham.ac.uk//id/eprint/3760/2/Decl_IS_Prince12PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Mutations of the WFS1 gene are responsible for most cases of Wolfram syndrome (WS), a rare, recessively inherited neurodegenerative disorder characterised by juvenile-onset nonautoimmune diabetes mellitus and optic atrophy. Variants of \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) are also associated with non-syndromic hearing loss and type-2 diabetes. Understanding the function of the \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) protein-product wolframin, would enable developments in targeted therapy for WS patients and important insights to its possible contribution to type-2 diabetes pathogenesis. This study was aimed at expanding the spectrum of WS-associated genetic mutations and clinical data, and investigating the molecular mechanisms responsible for phenotypic variation associated with \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\)- mutation. The mutational and phenotypic spectrum of WS is broadened by our report of novel \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) mutations and a case of \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x32}\\)-associated WS. New perspectives on the molecular mechanisms linking mutation to disease manifestation are also taken by characterisation of representative WFS1 mutations specific to phenotype, identification of potentially novel \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) interacting partners, and the first evidence linking WFS1 with the exocrine pancreas. Our data suggests that some \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\)-mutations may allow residual protein function and these findings lay the groundwork for future functional investigation of mutated wolframin to explore this hypothesis further."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["Mutation analysis of wolfram syndrome patients and functional study of the Wolframin protein"]}]}],"canonical_facts":{"dc:contributor.sponsor":["mrc"],"dc:creator":["Prince, Samantha"],"dc:date":["2013-07"],"dc:date.issued":["2013-07"],"dc:description.abstract":["Mutations of the WFS1 gene are responsible for most cases of Wolfram syndrome (WS), a rare, recessively inherited neurodegenerative disorder characterised by juvenile-onset nonautoimmune diabetes mellitus and optic atrophy. Variants of \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) are also associated with non-syndromic hearing loss and type-2 diabetes. Understanding the function of the \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) protein-product wolframin, would enable developments in targeted therapy for WS patients and important insights to its possible contribution to type-2 diabetes pathogenesis. This study was aimed at expanding the spectrum of WS-associated genetic mutations and clinical data, and investigating the molecular mechanisms responsible for phenotypic variation associated with \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\)- mutation. The mutational and phenotypic spectrum of WS is broadened by our report of novel \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) mutations and a case of \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x32}\\)-associated WS. New perspectives on the molecular mechanisms linking mutation to disease manifestation are also taken by characterisation of representative WFS1 mutations specific to phenotype, identification of potentially novel \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\) interacting partners, and the first evidence linking WFS1 with the exocrine pancreas. Our data suggests that some \\(\\char{cmti10}{0x57}\\)\\(\\char{cmti10}{0x46}\\)\\(\\char{cmti10}{0x53}\\)\\(\\char{cmti10}{0x31}\\)-mutations may allow residual protein function and these findings lay the groundwork for future functional investigation of mutated wolframin to explore this hypothesis further."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/3760/1/Prince12PhD.pdf","http://etheses.bham.ac.uk//id/eprint/3760/2/Decl_IS_Prince12PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Department of Medical and Molecular Genetics, School of Clinical and Experimental Medicine"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/3760/"],"dc:subject":["QH301 Biology","QH426 Genetics","RC Internal medicine"],"dcterms:accessrights":["public","staffonly"],"dc:title":["Mutation analysis of wolfram syndrome patients and functional study of the Wolframin protein"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:27:23Z"}